Biogenesis of miRNA: Canonical and Non-Canonical Pathways

Added:

The Biological Noise Hypothesis and the Functional Validity of Non-Canonical miRNAs

While textbooks detail various canonical and non-canonical miRNA biogenesis pathways, a significant debate in the field centers on the functional relevance of many identified non-canonical miRNAs. Skeptics and critical researchers argue that a vast majority of these non-canonical sequences—such as those derived from tRNAs, snoRNAs, or introns (mirtrons)—are actually degradation intermediates or 'transcriptional noise' rather than biologically active, programmed regulators. This perspective challenges the tendency to classify every small RNA sequence associated with Argonaute as a functional miRNA. Proponents of this view argue that strict evolutionary conservation and rigorous functional assays, rather than mere high-throughput sequencing detection, must be demonstrated before establishing a non-canonical fragment as a genuine miRNA. Consequently, this critical viewpoint warns against overestimating the complexity of non-canonical biogenesis pathways, suggesting many may represent biochemical byproducts rather than dedicated regulatory mechanisms.

The Central Dogma of Molecular Biology, specifically the transcription of DNA into RNA and the translation of mRNA into proteins.
The basic structure and classification of RNA molecules, distinguishing between coding (mRNA) and non-coding RNAs (ncRNAs).
The fundamentals of eukaryotic gene expression regulation, including the roles of promoters, transcription factors, and enhancers.
Standard RNA processing mechanisms in eukaryotes, such as splicing, 5' capping, and 3' polyadenylation.
The precise molecular mechanisms of miRNA-mediated gene silencing, including translational repression, mRNA deadenylation, and target degradation.
A comparative analysis of miRNAs with other small RNA pathways, such as small interfering RNAs (siRNAs) and Piwi-interacting RNAs (piRNAs).
The clinical relevance of dysregulated miRNA expression in human diseases, specifically their roles as oncogenes (oncomiRs) or tumor suppressors.
Therapeutic applications of RNA interference (RNAi), including the development of miRNA mimics and antagomirs for targeted gene therapy.
246 views3likes7:58@Informative_videosOriginal Release: 2024-04-06

MicroRNAs (miRNAs) are formed through two main pathways: the canonical pathway where pre-miRNAs are processed in the nucleus by the microprocessor complex (DROSHA and DGCR8), then transported to the cytoplasm where they interact with DICER to form the miRISC complex; and non-canonical pathways where maturation occurs in the cytoplasm. The miRISC complex regulates gene expression by either inhibiting mRNA translation or promoting mRNA degradation through decapping complexes, primarily affecting the eIF4F complex formation and poly(A) tail stability.